A detailed history of New York State Common Retirement Fund transactions in Castle Biosciences Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 183,931 shares of CSTL stock, worth $5.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
183,931
Previous 187,731 2.02%
Holding current value
$5.05 Million
Previous $4.09 Million 28.36%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$17.4 - $31.47 $66,120 - $119,586
-3,800 Reduced 2.02%
183,931 $5.25 Million
Q2 2024

Jul 31, 2024

SELL
$18.84 - $24.94 $769,576 - $1.02 Million
-40,848 Reduced 17.87%
187,731 $4.09 Million
Q1 2024

May 07, 2024

SELL
$18.06 - $25.3 $154,358 - $216,239
-8,547 Reduced 3.6%
228,579 $5.06 Million
Q4 2023

Feb 01, 2024

SELL
$12.19 - $22.43 $106,564 - $196,083
-8,742 Reduced 3.56%
237,126 $5.12 Million
Q3 2023

Nov 07, 2023

BUY
$13.28 - $20.3 $61,552 - $94,090
4,635 Added 1.92%
245,868 $4.15 Million
Q2 2023

Aug 07, 2023

BUY
$11.66 - $26.0 $236,791 - $528,008
20,308 Added 9.19%
241,233 $3.31 Million
Q1 2023

May 02, 2023

BUY
$19.47 - $28.49 $125,523 - $183,675
6,447 Added 3.01%
220,925 $5.02 Million
Q4 2022

Jan 30, 2023

BUY
$18.08 - $30.0 $167,131 - $277,320
9,244 Added 4.5%
214,478 $5.05 Million
Q3 2022

Nov 08, 2022

BUY
$22.51 - $34.32 $212,381 - $323,809
9,435 Added 4.82%
205,234 $5.35 Million
Q2 2022

Aug 04, 2022

BUY
$16.0 - $45.99 $750,960 - $2.16 Million
46,935 Added 31.53%
195,799 $4.3 Million
Q1 2022

May 05, 2022

BUY
$33.17 - $46.98 $686,220 - $971,922
20,688 Added 16.14%
148,864 $6.68 Million
Q4 2021

Feb 02, 2022

BUY
$39.06 - $67.58 $3.16 Million - $5.46 Million
80,837 Added 170.76%
128,176 $5.5 Million
Q3 2021

Nov 02, 2021

BUY
$60.13 - $77.6 $132,225 - $170,642
2,199 Added 4.87%
47,339 $3.15 Million
Q2 2021

Aug 02, 2021

BUY
$50.07 - $76.78 $722,109 - $1.11 Million
14,422 Added 46.95%
45,140 $3.31 Million
Q1 2021

May 11, 2021

BUY
$58.92 - $97.33 $335,844 - $554,781
5,700 Added 22.78%
30,718 $2.1 Million
Q4 2020

Feb 08, 2021

SELL
$43.6 - $73.05 $194,020 - $325,072
-4,450 Reduced 15.1%
25,018 $1.68 Million
Q3 2020

Nov 05, 2020

BUY
$38.47 - $52.03 $375,082 - $507,292
9,750 Added 49.45%
29,468 $1.52 Million
Q2 2020

Aug 07, 2020

BUY
$27.28 - $43.01 $387,867 - $611,516
14,218 Added 258.51%
19,718 $743,000
Q4 2019

Feb 05, 2020

BUY
$15.74 - $35.04 $86,570 - $192,720
5,500 New
5,500 $189,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $723M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.